Radiation-associated cardiovascular disease

Critical Reviews in Oncology/Hematology

Volumn 45, Issue 1, 2003, Pages 55-75

  Adams, M Jacob ^a   Hardenbergh, Patricia H ^b   Constine, Louis S ^a   Lipshultz, Steven E ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anthracyclines; Arrhythmia; Breast cancer; Cardiomyopathy; Cardiovascular disease; Coronary artery disease; Heart disease; Hodgkin's disease; Pericarditis; Radiation therapy; Valvular disease

Indexed keywords

AMIFOSTINE; ANTHRACYCLINE; RAZOXANE;

ARTERIOSCLEROSIS; ARTICLE; AUTONOMIC DYSFUNCTION; BREAST CANCER; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DOSE RESPONSE; FOLLOW UP; HEART ARRHYTHMIA; HODGKIN DISEASE; HUMAN; LUNG HYPOPLASIA; MEDLINE; PERICARDITIS; PULMONARY ARTERY STENOSIS; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION INJURY; RADIATION RESPONSE; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; TECHNIQUE; TREATMENT PLANNING; VALVULAR HEART DISEASE; HEART; MEDIASTINUM; NEOPLASM; RADIOTHERAPY; REVIEW;

CARDIOVASCULAR DISEASES; HEART; HUMANS; MEDIASTINUM; NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY;

EID: 0037212077     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(01)00227-X     Document Type: Review

References (146)

1. Stewart J.R., Fajardo L.F. Radiation-induced heart disease: an update. Prog. Cardiovasc. Dis. 27:(3):1984;173-194.
2. Arsenian M.A. Cardiovascular sequelae of therapeutic thoracic radiation. Prog. Cardiovasc. Dis. 33:(5):1991;299-311.
3. Gyenes G. Radiation-induced ischemic heart disease in breast cancer - a review. Acta. Oncol. 37:(3):1998;241-246.
4. Rutqvist L.E. Novel approaches using radiation therapies. Recent Results Cancer Res. 152:1998;255-264.
5. Taghian A.G., Powell S.N. The role of radiation therapy for primary breast cancer. Surg. Clin. North Am. 79:(5):1999;1091-1115.
6. Hancock S.L. Cardiovascular late effects after treatment of Hodgkin's disease. Mauch P., Armitage J.O., Diehl V., Hoppe R.T., Weiss L.M. Hodgkin's disease. 1999;647-660 Lippincott Williams and Wilkins, London.
7. Fajardo L.F., Stewart J.R., Cohn K.E. Morphology of radiation-induced heart disease. Archives of Pathology. 86:(5):1968;512-519.
8. Chello M., Mastroroberto P., Romano R., Zofrea S., Bevacqua I., Marchese A.R. Changes in the proportion of types I and III collagen in the left ventricular wall of patients with post-irradiative pericarditis. Cardiovasc. Surg. 4:(2):1996;222-226.
9. Orzan F., Brusca A., Gaita F., Giusetto C., Figliomeni M.C., Librero L. Associated cardiac lesions in patients with radiation-induced complete heart block. Int. J. Cardiol. 39:1993;151-156.
10. Cohen S.I., Bhareti S., Glass J., Lev M. Radiotherapy as a cause of complete atrioventricular heart block in Hodgkin's disease. An electrophysiological-pathological correlation. Arch. Intern. Med. 141:1981;676-679.
11. La Vecchia L. Physiologic dual chamber pacing in radiation-induced atrioventricular block. Chest. 110:1996;580-581.
12. Stewart J.R., Fajardo L.F., Gillette S.M., Constine L.S. Radiation injury to the heart. Int. J. Radiat. Oncol. Biol. Phys. 31:(5):1995;1205-1211.
13. Stewart J.R., Fajardo L.F. Radiation-induced heart disease. Clinical and experimental aspects. Radiol. Clin. North Am. 9:(3):1971;511-531.
14. Walden T.L., Farzaneh N.K. Biochemical response of normal tissue to ionizing radiation. Gutin P.H., Leibel S.A., Sheline G.E. Radiation injury to the nervous system. 1991;17-36 Raven Press, New York.
15. Brosius F.C., Waller B.F., Roberts W.C. Radiation heart disease. Analysis of 16 young (aged 15-33 years) necropsy patients who received over 3500 rads to the heart. Am. J. Med. 70:(3):1981;519-530.
16. Veinot J.P., Edwards W.D. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum. Pathol. 27:(8):1996;766-773.
17. Carlson R.G., Mayfield W., Normann S., Alexander J.A. Radiation-associated valvular disease. Chest. 99:(3):1991;538-545.
18. Horimoto M., Igarashi K., Takenaka T., Batra S. Pulmonary infundibular stenosis, coronary artery disease, and aortic regurgitation caused by mediastinal radiation. Am. Heart J. 126:(4):1993;1002-1005.
19. McEniery P.T., Dorosti K., Schiavone W., Pedrick T.J., Sheldon W.C. Clinical and angiographic features of coronary artery disease after chest irradiation. Am. J. Cardiol. 60:1987;1020-1024.
20. King V., Constine L.S., Clark D., et al. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 36:(4):1996;881-889.
21. Annest L.S., Anderson R.P., Li W., Hafermann M.D. Coronary artery disease following mediastinal radiation therapy. J. Thorac. Cardiovasc. Surg. 85:(2):1983;257-263.
22. McReynolds R.A., Gold G.L., Roberts W.C. Coronary heart disease after mediastinal irradiation for Hodgkin's disease. Am. J. Med. 60:(1):1976;39.
23. Joensuu H. Myocardial infarction after irradiation in Hodgkin's disease: a review. Recent Results Cancer Res. 130:1993;157-171.
24. Amromin G.D., Gildenhorn H.L., Solomon R.D., Nadkarni B.B., Jacobs M.L. The synergism of x-irradiation and cholesterol-fat feeding on the development of coronary artery lesions. J. Atheroscler. Res. 4:1964;325-334.
25. Fajardo L.F. Radiation-induced coronary artery disease. Chest. 71:(5):1977;563-564.
26. Lindsay S., Kohn H.I., Dakin R.L., Jew J. Aortic arteriosclerosis in the dog after localized aortic x-irradiation. Circ. Res. 10:1962;51-60.
27. Bradley E.W., Zook B.C., Casarett G.W., Rogers C.C. Coronary arteriosclerosis and atherosclerosis in fast neutron or photon irradiated dogs. Int. J. Radiat. Oncol. Biol. Phys. 7:1981;1103-1108.
28. Artom C., Lofland H.B., Cleland J.G. Ionizing radiation, atherosclerosis, and lipid metabolism in pigeons. Radiat. Res. 26:1965;165-177.
29. Marti V., Garcia J., Auge J.M., Obrador D., Ballester M. Coronary arterial spasm and cardiac arrest following mediastinal radiation therapy for Hodgkin's disease. Chest. 100:1991;1180-1181.
30. Pohjola-Sintonen S., Totterman K.J., Kupari M. Sick sinus syndrome as a complication of mediastinal radiation therapy. Cancer. 65:1990;2494-2496.
31. Perrault D.J., Levy M., Herman J.D., et al. Echocardiographic abnormalities following cardiac radiation. J. Clin. Oncol. 3:(4):1985;546-551.
32. Aisenberg A.C. Problems in Hodgkin's disease management. Blood. 93:(3):1999;761-779.
33. Lee C.K., Aeppli D., Nierengarten M.E. The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience. Int. J. Radiat. Oncol. Biol. Phys. 48:(1):2000;169-179.
34. Mauch P., Kalish L.A., Marcus K.C., et al. Long-term survival in Hodgkin's disease: relative impact of mortality, second tumors, infection and cardiovascular disease. Cancer J. Sci. Am. 1:1995;33-42.
35. Hoppe R.T. Hodgkin's disease: complications of therapy and excess mortality. Ann. Oncol. 8:(Suppl. 1):1997;115-118.
36. Hancock S.L., Tucker M.A., Hoppe R.T. Factors affecting late mortality from heart disease after treatment for Hodgkin's disease. J. Am. Med. Assoc. 270:1993;1949-1955.
37. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J. Clin. Oncol. 12:(3):1994;447-453.
38. Rutqvist L.E., Johansson H. Mortality by laterality of the primary tumor among 55,000 breast cancer patients from the Swedish center registry. Br. J. Cancer. 61:(6):1990;866-868.
39. Rutqvist L.E., Lax I., Fornander T., Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 22:1992;887-896.
40. Early Breast Cancer Trialists' Collaborative Group. Treatment of Early Breast Cancer, Vol. 1, Worldwide Evidence, 1985-1990. Oxford, UK Oxford University, 1990.
41. Effects of radiotherapy and surgery in early breast cancer. N. Engl. J. Med. 333:1995;1444-1455.
42. Jones J.M., Ribeiro G.G. Mortality pattern over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin. Radiol. 40:1989;204-208.
43. Host H., Brennhovd I.O., Lock M. Postoperative radiotherapy in breast cancer long-term results from the Oslo study. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;727-732.
44. Paszat L.F., Mackillop W.J., Groome P.A., Boyd C., Schulze K., Holowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J. Clin. Oncol. 16:(8):1998;2625-2631.
45. Cuzick J., Stewart H., Peto R., et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep. 71:1987;15-29.
46. Hojris I., Overgaard M., Christensen J.J., Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomized trials. Lancet. 354:(9188):1999;1425-1430.
47. Fisher B., Redmond C., Fisher E., et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiotherapy. N. Engl. J. Med. 312:1985;674-681.
48. Fisher B., Anderson S., Redmond C., Wolmark N., Wickerham D.L., Cronin W.M. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 333:(22):1995;1456-1461.
49. Whelan T.J., Julian J., Jadad A.R., Levine M.L. Does localregional radiation therapy improve survival in breast cancer? A meta-analysis. J. Clin. Oncol. 18:(6):2000;1220-1229.
50. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of randomised trials. Lancet. 355:(9217):2000;1757-1770.
51. Gyenes G., Gagliardi G., Lax I., Fornander T., Rutqvist L. Evaluation of irradiated heart volume in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J. Clin. Oncol. 15:(4):1997;1348-1353.
52. Gagliardi G., Lax I., Rutqvist L.E. Partial irradiation of the heart. Semin. Radiat. Oncol. 11:(3):2001;224-233.
53. Nixon A.J., Manola J., Gelman R., et al. No long term increase in cardiac related mortality after breast-conserving surgery and radiation therapy using modern techniques. J. Clin. Oncol. 16:(4):1998;1374-1379.
54. Rutqvist L.E., Liedberg A., Hammar N., Dalberg K. Myocardial infarction among women with early-stage breast cancer treated with conservative surgery and breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 40:(2):1998;359-363.
55. Paszat L.F., Mackillop W.J., Groome P.A., Schulze K., Holowaty E. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: population-based study in Ontario, Canada. Int. J. Radiat. Oncol. Biol. Phys. 43:(4):1999;755-762.
56. Vallis K., Pintilie M., Chong N., Holowaty E., Kirkbride P., Wielgosz A.T. Assessment of coronary heart disease morbidity and mortality following radiation therapy for early breast cancer (Abstract). Int. J. Radiat. Oncol. Biol. Phys. 48:(3S):2000;144-145.
57. Gyenes G., Rutqvist L.E., Liedberg A., Fornander T. Long-term cardiac morbidity and mortality in a randomized trial of pre- and post-operative radiation therapy versus surgery alone in primary breast cancer. Radiother. Oncol. 48:(2):1998;185-190.
58. Hancock S.L., Donaldson S.S., Hoppe R.T. Cardiac disease following treatment of Hodgkin's disease in children and adolescentsm. J. Clin. Oncol. 11:1993;1208-1215.
59. Reinders J.G., Heijmen B.J., Olofsen-van Acht M.J., van Putten W.L., Levendag P.C. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother. Oncol. 51:(1):1999;35-42.
60. Shimizu Y., Kato H., Schull W., Hoel D. Studies of mortality of A-bomb survivors: mortality 1950-1985. Part 3: Noncancer mortality based on the revised doses. Radiat. Res. 130:1992;249-266.
61. Boivin J.-F., Hutchison G., Lubin J., Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer. 69:1992;1241-1247.
62. Glanzmann C., Kaufmann P., Jenni R., Hess O.M., Huguenin P. Cardiac risk after mediastinal irradiation for Hodgkin's disease. Radiother. Oncol. 46:(1):1998;51-62.
63. Radwaner B.A., Geringer B., Goldman A.M., Schwartz M.J., Kemp H.G. Jr. Left main coronary artery stenosis following mediastinal irradiation. Am. J. Med. 82:(5):1987;1017-1020.
64. Rodgers D.L. Precocious myocardial infarction after radiation treatment for Hodgkin's disease. Chest. 70:(5):1911;675-677.
65. Totterman K.J., Pesonen E., Siltanen P. Radiation related chronic heart disease. Chest. 83:(6):1983;875-878.
66. Angelini A., Benciolini P., Thiene G. Radiation-induced coronary obstructive atherosclerosis and sudden death in a teenager. Int. J. Cardiol. 9:(3):1985;371-373.
67. Orzan F., Brusca A., Conte M.R., Presbitero P., Figliomeni M.C. Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment. Br. Heart J. 69:1993;496-500.
68. Carmel R.J., Kaplan H.S. Mantle irradiation in Hodgkin's disease. Cancer. 37:1976;2813-2815.
69. Martin RG, Ruckdeschel J, Chang P, Byhardt R, Bouchard RJ, Wiernik PH. Radiation-related pericarditis, Am J Cardiol 1975;35:216-220.
70. Pohjola-Sintonen S., Totterman K.J., Salmo M., Siltanen P. Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease. Cancer. 60:1987;31-37.
71. Ilhan I., Sarialoglu F., Ozbarlas N., Buyukpamukcu M., Akyuz C., Kutluk T. Late cardiac effects after treatment for childhood Hodgkin's disease with chemotherapy and low-dose radiotherapy. Postgrad. Med. J. 71:(833):1995;164-167.
72. Tolba K.A., Deliargyris E.N. Cardiotoxicity of cancer therapy. Cancer Invest. 17:(6):1999;408-422.
73. Burns R.J., Bar Shlomo B.Z., Druck M.N., et al. Detection of radiation cardiomyopathy by gated radionuclide angiography. Am. J. Med. 74:1983;297-301.
74. Constine L.S., Schwartz R.G., Savage D., King V., Muhs A. Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 39:(4):1997;897-906.
75. Hardenbergh P.H., Munley M.T., Bentel G.C., et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int. J. Radiat. Oncol. Biol. Phys. 49:(4):2001;1023-1028.
76. Gyenes G., Fornander T., Carlens P., Glas U., Rutqvist L.E. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study. Int. J. Radiat. Oncol. Biol. Phys. 36:1996;899-905.
77. Lipshultz S.E., Colan S.D., Gelber R.D., Perez-Atayde A.R., Salan S.E., Sanders S.P. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N. Engl. J. Med. 324:1991;808-815.
78. Billingham M.E., Bristow M.R., Glatstein E., Mason J.W., Masek M.A., Daniels J.R. Adriamycin cardiotoxicity: endomyocardial biopsy evidence of enhancement by irradiation. Am. J. Surg. Pathol. 1:1977;17-23.
79. Merrill J., Geco F.A., Zimber H., et al. Adriamycin and radiation: synergistic cardiotoxicity (Abstract). Ann. Intern. Med. 82:1975;122-123.
80. Kinsella T.J., Ahmann D.L., Giuliani E.R., et al. Adriamycin toxicity in stage IV breast cancer: possible enhancement with prior left chest radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 5:1979;1979-2002.
81. Pihkala J., Saarinen U., Lundstrom U., et al. Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiation. Eur. J. Cancer. 32A:(1):1996;97-103.
82. Leonard G.T., Green D.M., Spangenthal E.L., et al. Cardiac mortality and morbidity after treatment for Hodgkin disease during childhood and adolescence (Abstract). Pediatr. Res. 47:(4):2000;46A.
83. Shapiro C.L., Hardenbergh P.H., Gelman R., et al. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J. Clin. Oncol. 16:(11):1998;3493-3501.
84. Larsen R.L., Jakacki R.I., Vetter V.L., Meadows A.T., Silber J.H., Barber G. Electrocardiograhic changes and arrhythmias after cancer therapy in children and young adults. Am. J. Cardiol. 70:(1):1992;73-77.
85. Slama M.S., Le Guludec D., Sebag C., et al. Complete atrioventricular block following mediastinal irradiation: a report of six cases. Pacing Clin. Electrophysiol. 14:1991;1112-1118.
86. Schwartz C.L., Hobbie W., Truesdell S., Constine L.C., Clark E.B. Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer. J. Clin. Oncol. 11:(10):1993;1906-1910.
87. Strender L.E., Lindahl J., Larsson L.E. Incidence of heart disease and functional significance of changes in electrocardiogram 10 years after radiotherapy for breast cancer. Cancer. 57:1986;929-934.
88. Constine L.S. Late effects of cancer treatment. Halperin E.C., Constine L.S., Tarbell N.J., Kun L.E. Pediatric radiation oncology. 1999;457-537 Lippincott, Williams and Wilkins, New York.
89. Van Renterghem D., Hamers J., De Shryver A., Pauwels R., Van der Straeten M. Chylothorax after mantle irradiation for Hodgkin's disease. Respiration. 48:1985;188-189.
90. Cameron E.H., Lipshultz S.E., Tarbell N.J., Mauch P. Cardiovascular disease in long-term survivors of pediatric Hodgkin's disease. Prog. Pediatr. Cardiol. 8:(3):1998;139-144.
91. Polikar R., Burger A.G., Scherrer U., Nicod P. The thyroid and the heart. Circulation. 87:(5):1993;1435-1441.
92. Patel A.R., Konstam M.A. Assessment of the patient with heart failure. Crawford M.H., DiMarco J.P. Cardiology. 2001;5.2.1-5.2.10 Mosby International Ltd, London.
93. Loyer E.M., Delpassand E.S. Radiation-induced heart disease: imaging features. Semin. Roentgenol. 28:(4):1993;321-332.
94. Bellenger N.G., Burgess M.I., et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable? Eur. Heart J. 21:(16):2000;1387-1396.
95. Expert panel on detection evaluation, and treatment of high blood cholesterol in adults. Executive Summary of the Third Report of the National Cholesterol Education Program, J Am Med Assoc 2001;285(19):2486-2497.
96. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342:(12):2000;836-843.
97. Stein E. Laboratory surrogates for anti-atherosclerotic drug development. Am. J. Cardiol. 87 Suppl. 2001;21A-26A.
98. Ridker P.M. High-sensitivity C-reactive protein: a novel inflammatory marker for predicting the risk of coronary artery disease. Adams J.E., et al. Markers in cardiology: current and future clinical application. 2001;173-184 Futura Publishing Co, Armonk, NY.
99. Ridker P.M., Rifai N. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin. Chem. 47:(3):2001;403-411.
100. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336:(14):1997;973-979.
101. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 349:(9050):1997;462-466.
102. Lee T.H., Boucher C.A. Noninvasive tests in patients with stable coronary artery disease. N. Engl. J. Med. 344:(24):2001;1840-1845.
103. Gyenes G., Fornander T., Carlens P., Glas U., Rutqvist L.E. Detection of radiation-induced myocardial damage by Technietium 99m Sestamibi scintigraphy. Eur. J. Nucl. Med. 24:(3):1997;286-292.
104. Maunoury C., Pierga J.Y., Valette H., Tchernia G., Cosset J.M., Desgrez A. Myocardial perfusion damage after mediastinal irradiation for Hodgkin's disease: a Thalium-201 single photon emission tomography study. Eur. J. Nucl. Med. 19:1992;871-873.
105. Girinsky T., Cordova A., Rey A., Cosset J.M., Tertian G., Pierga J.Y. Thallium-201 scinigraphy is not predictive of late cardiac complications in patients with Hodgkin's disease treated with mediastinal irradiation. Int. J. Radiat. Oncol. Biol. Phys. 48:(5):2000;1503-1506.
106. Mancini D.M., Eisen H., Kussmaul W., Mull R., Edmunds L.H., Wilson J.R. Value of peak exercise oxygen consumption for the optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 83:1991;778-786.
107. Lipshultz S.E., Fisher S.D., Lai W.W., Miller T.L. Cardiovascular monitoring and therapy for HIV-infected patients. Ann. NY Acad. Sci. 946:2001;236-273.
108. Pihkala J., Happonen J.M., Virtanen K., et al. Cardiopulmonary evaluation of exercise tolerance after chest irradiation and anticancer chemotherapy in children and adolescents. Pediatrics. 95:1995;722-726.
109. McKillop J.H., Bristow M.R., Goris M.L., Billingham M.E., Bockemuehl K. Sensitivity and specificity of radionuclide ejection fraction in doxorubicin cardiotoxicity. Am. Heart J. 106:1983;1048-1056.
110. Arad Y., Spadaro L.A., Goodman K., et al. Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow up of 1173 asymptomatic subjects. Circulation. 93:(11):1996;1951-1953.
111. Grundy S.M. Coronary calcium as a risk factor: role in global risk assessment. J. Am. Coll. Cardiol. 37:2001;1512-1515.
112. Arad Y., Spadaro L.A., Goodman K., Newstein D., Guerci A.D. Prediction of coronary events with electron beam computed tomography. J. Am. Coll. Cardiol. 36:(4):2000;1253-1260.
113. Detrano R.C., Wong N.D., Doherty T.M., et al. Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation. 99:(20):1999;2633-2638.
114. Secci A., Wong N., Tang W., Wang S., Doherty T., Detrano R. Electron beam computed tomographic coronary calcium as a predictor of coronary events: comparison of two protocols. Circulation. 96:(4):1997;1122-1129.
115. Raggi P., Callister T.Q., Cooil B., et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation. 101:(6):2000;850-857.
116. Hecht H.S., Superko H.R. Electron beam tomography and national cholesterol education program guidelines in asymptomatic women. J. Am. Coll. Cardiol. 37:2001;1506-1511.
117. O'Malley P.G., Taylor A.J., Jackson J.L., Doherty T.M., Detrano R.C. Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations. Am. J. Cardiol. 85:2000;945-948.
118. O'Rourke R.A., Brundage B.H., Froelicher V.F., et al. American college of cardiology/American Heart Association expert concensus document on electron beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation. 102:2000;126-140.
119. Levitt G.A., Jenney M.E.M. The reproductive system after childhood cancer. Br. J. Obstet. Gynaecol. 105:1998;946-953.
120. Glanzmann C., Huguenin P., Lutolf U.M., Maire R., Jenni R., Gumppenberg V. Cardiac lesions after mediastinal radiation for Hodgkin's disease. Radiother. Oncol. 30:(1):1994;43-54.
121. Simbre V.C. II, Adams M.J., Deshpande S.S., Duffy S.A., Miller T.L., Lipshultz S.E. Cardiomyopathy caused by antineoplastic drugs. Curr. Treat. Options Cardiovasc. Med. 3:(6):2001;493-505.
122. Sato M., Maulik G., Bagchi D., Das D.K. Myocardial protection by protykin, a novel extract of trans-Resveratrol and Emodin. Free Radic. Res. 32:(2):2000;135-144.
123. Koukourakis M.I., Kyrias G., Kakolyris S., et al. Subcutaneous administration of Amifostine during fractionated radiotherapy: a randomized phase II study. J. Clin. Oncol. 18:(11):2000;2226-2233.
124. Brizel D.M., Wasserman T.H., Henke M., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J. Clin. Oncol. 18:(19):2000;3339-3345.
125. Morton D.L., Glancy D., Joseph W.L., et al. Management of patients with radiation-induced pericarditis with effusion: a note on the development of regurgitaion in two of them. Chest. 64:1973;291-297.
126. Palatianos G.M., Thurer R.J., Kaiser G.A. Comparison of effectiveness and safety of operations on the pericardiumm. Chest. 88:(1):1985;30-33.
127. Ni Y., von Segesser L., Turina M. Futility of pericardiectomy for postirradiation constrictive pericarditis? Ann. Thorac. Surg. 49:(445):1990;448.
128. Om A., Vetrovec G.W. Coronary angioplasty of radiation-induced stenosis. Am. Heart J. 125:(4):1993;1164-1166.
129. Veeragandham R.S., Goldin M.D. Surgical management of radiation-induced heart disease. Ann. Thorac. Surg. 65:(4):1998;1014-1019.
130. Handler C.E., Livesey S., Lawton P.A. Coronary ostial stenosis after radiotherapy: angioplasty or coronary artery surgery? Br. Heart J. 61:1989;209-211.
131. Nakhjavan F.K., Yazdanfar S., Friedman A. Percutaneous transluminal coronary angiopasty for stenosis of the ostium of the right coronary artery after irradiation for Hodgkin's disease. Am. J. Cardiol. 53:(2):1984;341-342.
132. Hicks G.L. Jr. Coronary artery operation in radiation-associated atherosclerosis: long-term follow-up. Ann. Thorac. Surg. 53:(4):1992;670-674.
133. Handa N., McGregor C.G., Danielson G.K., et al. Coronary artery bypass grafting in patients with previous mediastinal radiation therapy. J. Thorac. Cardiovasc. Surg. 117:(6):1999;1136-1142.
134. Ellis G.R., Penny W.J. Hibernating myocardium caused by isolated, radiation-induced left main stem coronary artery stenosis. Heart. 78:(4):1997;419-420.
135. Gharagozloo F., Clements I., Mullany C. Use of the internal mammary artery for myocardial revascularization in a patient with radiation-induced coronary artery disease. Mayo Clin. Proc. 67:(11):1992;1081-1084.
136. van Son J.A., Noyez L., van Asten W. Use of internal mammary artery in myocardial revascularization after mediastinal irradiation. J. Thorac. Cardiovasc. Surg. 104:(6):1992;1539-1544.
137. Reber D., Birnbaum D.E., Tollenaere P. Heart diseases following mediastinal irradiation: surgical management. Eur. J. Cardiothorac. Surg. 9:(4):1995;202-205.
138. Gaudiani V.A., Siegel S.B., McIntosh-Yellin N.L. Left main coronary artery reconstruction after radiation therapy. Ann. Thorac. Surg. 58:(2):1994;567-569.
139. Lipshultz S.E., Sallan S.E. Cardiovascular abnormalities in long-term survivors of childhood malignancy. J. Clin. Oncol. 11:(7):1993;1199-1203.
140. Kodama K., Fujiwara S., Yamada M., Kasagi F., Shimizu Y., Shigematsu I. Profiles of non-cancer disease in atomic bomb survivors. World Health Statistics Quarterly-Rapport Trimestriel de Statistiques Saintaires Mondiales. 49:(1):1996;7-16.
141. Hancock SL. Cardiac Toxicity After Cancer Therapy, National Cancer Institute, March 3, 1998.
142. Warda M., Khan A., Massumi A., Mathur V., Klima T., Hall R.J. Radiation-induced valvular dysfuction. J. Am. Coll. Cardiol. 2:1983;180-185.
143. Eriksson F., Gagliardi G., Liedberg A., et al. Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model. Radiother. Oncol. 55:2000;153-162.
144. Jakacki R.I., Goldwein J.W., Larsen R.L., Barber G., Silber J.H. Cardiac dysfunction following spinal irradiation during childhood. J. Clin. Oncol. 11:1993;1033-1038.
145. Adams M.J., Constine L.S., Lipshultz S.E. Radiation. Crawford M.H., DiMarco J.P. Cardiology. 2001;8.15.1-8.15.8 Mosby International Ltd, London.
146. Constine L.S. Late effects of cancer therapy. Halperin E.C., Constine L.S., Tarbell N.J., Kun L.E. Pediatric radiation oncology. 1999;457-537 Lippincott, Williams and Wilkins, New York.